Shilajit side effects, safety, and who should avoid it

Shilajit is often described as gentle, and for short-term use of a purified, tested product that is broadly what small trials suggest. But there are real side effects, at least one serious documented reaction, and several groups who should avoid it. This guide separates what is documented from what is theoretical, and grades each point so you can see how solid it is.

The general safety picture

Within its limits, the tolerability data are fairly encouraging. Short-term trials of purified, standardised material at typical doses have not reported serious problems. The key word is short-term.

Purified shilajit at 250 to 500 mg per day was well tolerated with no serious adverse events in short-term human trials of up to about 90 days. [Stohs 2014] Moderate evidence

An 8-week randomised trial of standardised shilajit at 250 or 500 mg per day in healthy adults reported zero adverse events and high adherence. [Keller 2019, JISSN] Moderate evidence

Set against that, independent bodies are blunt that the safety file is thin. There is very little from well-designed independent research, and long-term use beyond roughly three months is genuinely unstudied. Tolerated in a short trial is not the same as proven safe over time.

No standardised independent research defines a full side-effect profile for shilajit, and long-term safety beyond about three months is unstudied, with most data coming from animal studies. [OPSS (US DoD)] Strong evidence

The common side effects

The complaints people report most are mild and mostly digestive, and they tend to cluster at higher doses or when taken on an empty stomach.

The most commonly reported shilajit side effects are mild and gastrointestinal, including nausea, bloating and loose stools, plus occasional headache and dizziness, especially at higher doses or on an empty stomach. [Cleveland Clinic] Moderate evidence

Because shilajit can raise testosterone, women in particular may notice androgen-related effects such as acne, and some clinical sources list changes to hair or menstrual cycles. Taking a purified product with food and not megadosing are the practical steps most likely to reduce the mild effects. We cover this in the how to take guide.

The serious reactions that are documented

Two serious patterns are worth knowing. The first is allergy. A genuine hypersensitivity reaction is the one clearly documented serious effect, and it warrants stopping immediately.

Severe allergic or hypersensitivity reactions to shilajit are possible, including rash, hives, raised heart rate and facial or throat swelling, and warrant stopping immediately. [WebMD monograph] Moderate evidence

The second is rarer but instructive. There is a published case of a dangerous licorice-like syndrome affecting blood pressure and potassium after months of daily use during pregnancy. It is a single case, but a clinically serious one that feeds directly into the blood-pressure and pregnancy cautions below.

A pregnant woman developed pseudohyperaldosteronism, a licorice-like syndrome causing high blood pressure, low potassium and metabolic alkalosis, after roughly six months of daily mumijo or shilajit use. [Stavropoulos 2018] Preliminary evidence

Drug interactions, graded honestly

Here honesty means admitting how little is proven. Most listed interactions are mechanistic or precautionary rather than demonstrated in dedicated human studies. That does not make them safe to ignore, but you should know which are documented and which are extrapolated.

Shilajit may have mild antiplatelet activity, so combining it with blood thinners could theoretically raise bleeding risk, though there is no dedicated human interaction trial. [Cleveland Clinic] Preliminary evidence

Shilajit adds iron and fulvic acid enhances iron absorption, so it can add to iron loading, which is directly relevant to iron-overload conditions. [Healthline] Moderate evidence

Blood-pressure and blood-sugar interactions are plausible and bidirectional, so monitoring is sensible if you take antihypertensive or antidiabetic medication. Some frequently repeated interactions, including those with lithium, thyroid medication, and immunosuppressants, have no shilajit-specific evidence at all and are extrapolated from general principles. We flag them so you can raise them with a prescriber, not because they are proven.

A suggested lithium interaction has no shilajit-specific evidence and is extrapolated from lithium's narrow therapeutic index combined with shilajit's electrolyte effects, so it should be treated as theoretical and cleared with a prescriber. [OPSS (US DoD)] Insufficient evidence

Who should avoid shilajit

Merging the clinical sources gives a fuller avoid list than any single competitor publishes. Avoid shilajit, or use it only with explicit medical supervision, if you fall into these groups.

People with hemochromatosis or other iron-overload disorders should avoid shilajit, because it contributes iron and fulvic acid enhances iron absorption. [Cleveland Clinic] Moderate evidence

People with sickle cell anemia or thalassemia, which are prone to iron accumulation, should avoid shilajit. [Healthline] Moderate evidence

Pregnant and breastfeeding people should avoid shilajit, given the absence of safety data, a documented serious reaction during pregnancy, and heightened fetal risk from any heavy-metal exposure. [Stavropoulos 2018] Moderate evidence

• Children and adolescents, who have no pediatric safety data and are most vulnerable to heavy-metal neurotoxicity.
• Anyone taking blood thinners, or with a bleeding or clotting disorder.
• People with heart disease, or high, low, or uncontrolled blood pressure.
• People with diabetes or on glucose-lowering drugs, who should monitor blood sugar.
• Anyone on lithium, or with an autoimmune condition or on immunosuppressants.
• People with gout, or liver or kidney disease, where the picture is uncertain.
• Anyone allergic to shilajit, mumijo, or mineral pitch.
• Anyone who cannot obtain a purified product with a recent third-party heavy-metal Certificate of Analysis.

What the research does not support

Shilajit is not uniformly safe, and it does carry side effects, whatever a product page implies. The honest summary is that short-term use of a purified, tested product appears well tolerated in small trials, long-term safety is unstudied, a few serious reactions are documented, and the government posture across regulators is consistent: no approval, insufficient data, and caution. When in doubt, do not, and speak to a clinician first.

For the closely related contamination question, see our guide to heavy metals in shilajit. The buying guide covers choosing a tested product, and the FAQ answers the practical questions people ask most.

References

1. Stohs SJ. Safety and efficacy of shilajit. Phytother Res. 2014;28(4):475-9. PMID 23733436
2. Keller JL, et al. The effects of shilajit supplementation on fatigue-induced decreases in muscular strength. J Int Soc Sports Nutr. 2019;16(1):3. PMID 30728074
3. Stavropoulos K, et al. Pseudohyperaldosteronism due to mumijo consumption during pregnancy: a licorice-like syndrome. Gynecol Endocrinol. 2018;34(12):1019-21. PMID 29933704
4. Cleveland Clinic. Shilajit benefits and side effects. Cleveland Clinic
5. WebMD. Shilajit monograph. WebMD
6. Healthline. Shilajit. Healthline
7. US DoD Operation Supplement Safety. Shilajit as a dietary supplement ingredient. OPSS